Pharmaceutical combination comprising a class III receptor tyrosine kinase inhibitor and the alkylating histone-deacetylase inhibitor fusion molecule EDO-S101 together with its use in the treatment of cancer

• 收藏
• 分享

专利权人:

Euro-Celtique S.A.

发明人:

Mehrling, Thomas Jorg

申请号：

AU2015266050

公开号：

AU2015266050A1

申请日:

2015.05.26

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

The present invention is directed to a combination comprising a class III receptor tyrosine kinase inhibitor and a compound of formula I or a pharmaceutically acceptable salt thereof: to a pharmaceutical composition and to a kit both comprising said combination, to the combination, composition or kit for use in the treatment of cancer, and to a method of treatment of cancer in a patient in need thereof comprising administering to said patient an effective amount of said combination, composition or kit.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/